DRKS00000632尚未招募不适用
Identification of exacerbation markers in chronic inflammatory airway diseases
Forschungszentrum BorstelLaborgruppe Mukosaimmunologie0 个研究点目标入组 120 人开始时间: 2011年4月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Status of the donor:
- •a) confirmed chronic inflammatory airway disease (asthma or COPD) or
- •b) infection of the upper airways in the absence of a chronic inflammatory airway disease or
排除标准
- •The patient is not able to give his/her informed consent. The patient is in any relationship of dependency with the participating institutions
研究者
相似试验
尚未招募
不适用
Exacerbation indicators in patients with noninvasive home ventilatioJ44.0J96.11Chronic obstructive pulmonary disease with acute lower respiratory infectionDRKS00029273Kliniken der Stadt Köln gGmbH, Lungenklinik Standort-Merheim85
尚未招募
不适用
Exploratory study of exacerbation detection using respiratory stability time in COVID-19 patientsJPRN-jRCT1052200163Sawa Yoshiki65
已完成
不适用
Identification of predictive biomarkers for severe progression of COVID-19U07.1COVID-19, virus identifiedDRKS00021591Bundeswehrkrankenhaus Berlin, Klinik I (Innere Medizin)135
招募中
Unknown
nreported symptomatic exacerbation and progressive pulmonary fibrosis in patients with interstitial lung disease: prospective observational study using a disease management system (YaDoc)Interstitial Lung DiseaseJPRN-UMIN000049420Tosei General Hospital40
招募中
不适用
Biomarker study for exacerbation predictive markers in patients with COVID-19COVID-19JPRN-UMIN000044212Kanazawa University200